Location History:
- Sherwood Park, CA (1991 - 1995)
- Edmonton, CA (2001)
Company Filing History:
1 out of 2 
1 out of 16 
1 out of 832,912 Years Active: 1991-2001
Title: The Innovative Contributions of Antoine A Noujaim
Introduction
Antoine A Noujaim is a notable inventor based in Sherwood Park, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of novel protein conjugation techniques and cancer diagnostics. With a total of 3 patents, Noujaim's work has the potential to impact both in vitro and in vivo medical applications.
Latest Patents
Noujaim's latest patents include groundbreaking innovations. One of his patents focuses on the photoactivation of proteins for conjugation purposes. This process involves subjecting proteins, such as antibodies containing disulfide bonds, to ultraviolet radiation. This treatment reduces the disulfide bonds to reactive sulfhydryl groups, allowing the photoactivated protein to react with other chemical entities, including radiometals and drugs, to create useful conjugates for diagnosis and therapy.
Another significant patent involves carcinoma-marking monoclonal antibodies elicited with synthetic antigens. These monoclonal antibodies are produced after immunization with a synthetic antigen that is linked to a carrier moiety. They serve as effective carcinoma markers and can be tagged with radiometals or radiohalogens for radioimmunoimaging applications. The radiolabeled monoclonal antibody 155H.7, elicited by this antigen, has shown rapid localization and persistence in tumor tissues, demonstrating its utility as a tumor imaging agent.
Career Highlights
Throughout his career, Noujaim has worked with various organizations, including Summa Medical Corporation. His innovative approaches and research have positioned him as a key figure in the biotechnology sector, contributing to advancements in medical diagnostics and therapeutic techniques.
Collaborations
Noujaim has collaborated with notable professionals in his field, including Bryan M Longenecker and Thomas R Sykes. These collaborations have further enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Antoine A Noujaim's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work in protein conjugation and cancer diagnostics continues to pave the way for advancements in medical science.